Skip to content
Disclosery

PFM Health Sciences, LP

Follow

13F filer, CIK 1442756, SAN FRANCISCO, CA

PFM Health Sciences, LP reported $1,165,441,614 across 98 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 34.3% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001442756-26-000006

Period
2026-06-30
Reported value
$1.17B
Holdings
98
Top 10 weight
34.3%
New
35
Sold out
20

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ASNDnew+233,171$62.2M
HUMnew+94,375$37.5M
MTDnew+13,344$17M
MRKnew+127,118$16.3M
CYTKnew+191,686$16.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
THCreduced-271,995-$50.9M
ASNDexited-152,034-$34.8M
LLYreduced-26,504-$31.8M
PENreduced-79,558-$25.1M
GKOSexited-215,685-$23.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001442756-26-000006, largest first. % of portfolio is the value over $1,151,828,318, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 233,171 shares 233,171$62.2M5.4%newTimeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 467,427 shares; 2024Q4: 467,427 shares; 2025Q1: 556,545 shares; 2025Q2: 483,105 shares; 2025Q3: 530,332 shares; 2025Q4: 251,562 shares; 2026Q1: 264,304 shares; 2026Q2: 219,596 shares 219,596$53.8M4.67%-44,708Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 298,643 shares; 2024Q4: 298,643 shares; 2025Q1: 273,778 shares; 2025Q2: 268,023 shares; 2025Q3: 225,139 shares; 2025Q4: 68,289 shares; 2026Q1: 65,762 shares; 2026Q2: 39,258 shares 39,258$47.1M4.09%-26,504Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 17,597 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,511 shares; 2026Q1: 178,144 shares; 2026Q2: 160,768 shares 160,768$38.7M3.36%-17,376Timeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 101,954 shares; 2024Q4: 83,037 shares; 2025Q1: 63,238 shares; 2025Q2: 109,511 shares; 2025Q3: 3,648 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 94,375 shares 94,375$37.5M3.25%newTimeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 75,588 shares; 2024Q4: 75,588 shares; 2025Q1: 35,904 shares; 2025Q2: 34,623 shares; 2025Q3: not reported; 2025Q4: 50,539 shares; 2026Q1: 58,038 shares; 2026Q2: 88,276 shares 88,276$36.7M3.19%+30,238Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 166,803 shares; 2025Q1: not reported; 2025Q2: 12,821 shares; 2025Q3: 57,246 shares; 2025Q4: 163,197 shares; 2026Q1: 215,678 shares; 2026Q2: 213,407 shares 213,407$36M3.12%-2,271Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 135,546 shares; 2024Q4: 135,546 shares; 2025Q1: 439,283 shares; 2025Q2: 244,261 shares; 2025Q3: 239,644 shares; 2025Q4: 265,517 shares; 2026Q1: 305,431 shares; 2026Q2: 308,385 shares 308,385$29.2M2.54%+2,954Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 52,500 shares; 2025Q1: not reported; 2025Q2: 36,391 shares; 2025Q3: 95,650 shares; 2025Q4: 67,743 shares; 2026Q1: 39,805 shares; 2026Q2: 49,991 shares 49,991$27.1M2.35%+10,186Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 331,069 shares; 2025Q4: 151,453 shares; 2026Q1: 140,770 shares; 2026Q2: 143,222 shares 143,222$26.8M2.33%+2,452Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 116,532 shares; 2024Q4: 128,637 shares; 2025Q1: 41,038 shares; 2025Q2: 88,181 shares; 2025Q3: 133,683 shares; 2025Q4: 115,336 shares; 2026Q1: 57,500 shares; 2026Q2: 136,482 shares 136,482$23.7M2.06%+78,982Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 589,409 shares; 2024Q4: 491,334 shares; 2025Q1: 491,334 shares; 2025Q2: 499,243 shares; 2025Q3: 461,654 shares; 2025Q4: 397,767 shares; 2026Q1: 398,567 shares; 2026Q2: 126,572 shares 126,572$23.7M2.06%-271,995Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 390,863 shares; 2024Q4: 594,172 shares; 2025Q1: 379,954 shares; 2025Q2: 392,503 shares; 2025Q3: 381,324 shares; 2025Q4: 246,835 shares; 2026Q1: 254,510 shares; 2026Q2: 250,453 shares 250,453$22.7M1.97%-4,057Timeline
WATWATERS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 51,063 shares; 2024Q4: 59,053 shares; 2025Q1: 51,858 shares; 2025Q2: 43,089 shares; 2025Q3: 30,751 shares; 2025Q4: 43,208 shares; 2026Q1: 39,763 shares; 2026Q2: 59,825 shares 59,825$22.4M1.95%+20,062Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 166,261 shares; 2024Q4: 166,261 shares; 2025Q1: 166,261 shares; 2025Q2: 166,261 shares; 2025Q3: 195,085 shares; 2025Q4: 145,171 shares; 2026Q1: 139,779 shares; 2026Q2: 60,221 shares 60,221$19M1.65%-79,558Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 290,242 shares; 2025Q1: 908,135 shares; 2025Q2: 521,793 shares; 2025Q3: 327,174 shares; 2025Q4: 306,506 shares; 2026Q1: 257,747 shares; 2026Q2: 253,358 shares 253,358$18.9M1.64%-4,389Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 67,014 shares; 2024Q4: 32,349 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,852 shares; 2026Q1: 21,957 shares; 2026Q2: 56,637 shares 56,637$17.8M1.55%+34,680Timeline
MTDMETTLER TOLEDO INTERNATIONALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,344 shares 13,344$17M1.48%newTimeline
INDVINDIVIOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 574,666 shares; 2026Q2: 401,208 shares 401,208$16.5M1.43%-173,458Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 542,811 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 236,468 shares; 2025Q4: 187,834 shares; 2026Q1: not reported; 2026Q2: 127,118 shares 127,118$16.3M1.42%newTimeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,757,192 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 191,686 shares 191,686$16.3M1.42%newTimeline
LNTHLANTHEUS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 146,403 shares 146,403$16.2M1.41%newTimeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 144,501 shares; 2025Q1: 135,398 shares; 2025Q2: not reported; 2025Q3: 574,360 shares; 2025Q4: 725,424 shares; 2026Q1: 263,486 shares; 2026Q2: 248,867 shares 248,867$16M1.39%-14,619Timeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 74,363 shares; 2025Q4: 100,802 shares; 2026Q1: 169,829 shares; 2026Q2: 220,890 shares 220,890$15.8M1.38%+51,061Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,258 shares; 2026Q1: 34,146 shares; 2026Q2: 29,313 shares 29,313$15.7M1.37%-4,833Timeline
ACHCACADIA HEALTHCARE COMPANY INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 686,150 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 582,745 shares; 2026Q2: 524,934 shares 524,934$15.5M1.35%-57,811Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 174,052 shares; 2026Q2: 158,825 shares 158,825$15.1M1.31%-15,227Timeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 860,821 shares; 2024Q4: 860,821 shares; 2025Q1: 860,821 shares; 2025Q2: 735,033 shares; 2025Q3: 820,642 shares; 2025Q4: 499,837 shares; 2026Q1: 499,837 shares; 2026Q2: 519,016 shares 519,016$14.8M1.29%+19,179Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 58,433 shares; 2024Q4: 21,040 shares; 2025Q1: 21,897 shares; 2025Q2: not reported; 2025Q3: 2,314 shares; 2025Q4: 37,915 shares; 2026Q1: 14,832 shares; 2026Q2: 28,496 shares 28,496$14.3M1.24%+13,664Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 312,305 shares; 2025Q2: 479,005 shares; 2025Q3: 346,679 shares; 2025Q4: 107,767 shares; 2026Q1: not reported; 2026Q2: 137,457 shares 137,457$14.2M1.23%newTimeline
MMSIMERIT MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 162,469 shares; 2026Q2: 197,038 shares 197,038$13.7M1.19%+34,569Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 183,092 shares; 2024Q4: 119,509 shares; 2025Q1: 160,866 shares; 2025Q2: 84,713 shares; 2025Q3: 60,578 shares; 2025Q4: 31,163 shares; 2026Q1: 35,438 shares; 2026Q2: 38,575 shares 38,575$12.9M1.12%+3,137Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 52,120 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 133,161 shares; 2026Q1: 324,957 shares; 2026Q2: 342,751 shares 342,751$12.8M1.11%+17,794Timeline
NVONOVO-NORDISK A SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 197,181 shares; 2026Q2: 265,016 shares 265,016$12.7M1.1%+67,835Timeline
ITGRINTEGER HLDGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 106,585 shares; 2026Q1: 135,081 shares; 2026Q2: 126,669 shares 126,669$11.8M1.03%-8,412Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 67,840 shares; 2025Q4: 99,576 shares; 2026Q1: 172,137 shares; 2026Q2: 121,222 shares 121,222$11.8M1.03%-50,915Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 205,317 shares; 2026Q2: 249,020 shares 249,020$11.7M1.02%+43,703Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 71,018 shares; 2026Q1: not reported; 2026Q2: 90,858 shares 90,858$11.5M1%newTimeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 48,162 shares; 2025Q4: 40,210 shares; 2026Q1: 136,621 shares; 2026Q2: 101,550 shares 101,550$11.3M0.98%-35,071Timeline
HSICSCHEIN HENRY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 153,114 shares; 2026Q2: 134,423 shares 134,423$11.2M0.97%-18,691Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 64,279 shares; 2026Q2: 131,667 shares 131,667$10.7M0.93%+67,388Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 406,245 shares; 2026Q2: 326,047 shares 326,047$10.2M0.88%-80,198Timeline
TFXTELEFLEX INCORPORATEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 102,395 shares; 2026Q1: not reported; 2026Q2: 79,708 shares 79,708$10.1M0.88%newTimeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,729 shares; 2025Q3: 183,538 shares; 2025Q4: 188,956 shares; 2026Q1: 263,106 shares; 2026Q2: 255,330 shares 255,330$9.96M0.86%-7,776Timeline
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 118,525 shares; 2026Q1: 187,335 shares; 2026Q2: 141,914 shares 141,914$9.9M0.86%-45,421Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 513,685 shares; 2025Q4: 107,690 shares; 2026Q1: 174,867 shares; 2026Q2: 224,289 shares 224,289$9.62M0.84%+49,422Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 207,446 shares; 2026Q2: 268,008 shares 268,008$9.48M0.82%+60,562Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 157,874 shares; 2025Q4: 163,967 shares; 2026Q1: 165,925 shares; 2026Q2: 128,286 shares 128,286$9.11M0.79%-37,639Timeline
AMRXAMNEAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 355,818 shares; 2025Q4: 1,465,480 shares; 2026Q1: 930,096 shares; 2026Q2: 480,715 shares 480,715$8.32M0.72%-449,381Timeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 540,871 shares; 2026Q2: 1,210,661 shares 1,210,661$8M0.69%+669,790Timeline
IRTCIRHYTHM HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 88,157 shares; 2025Q3: 64,998 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 65,196 shares 65,196$7.76M0.67%newTimeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 114,719 shares; 2026Q2: 193,315 shares 193,315$7.53M0.65%+78,596Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 140,432 shares; 2026Q2: 82,230 shares 82,230$7.46M0.65%-58,202Timeline
WSTWEST PHARMACEUTICAL SVSC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,365 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,733 shares 20,733$7.44M0.65%newTimeline
TAKTAKEDA PHARMACEUTICAL CO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 444,173 shares 444,173$7.12M0.62%newTimeline
HNGEHINGE HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 82,860 shares 82,860$6.88M0.6%newTimeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 923,375 shares; 2025Q3: 360,460 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 242,069 shares 242,069$6.35M0.55%newTimeline
IARTINTEGRA LIFESCIENCES HLDGS CQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 348,746 shares 348,746$6.26M0.54%newTimeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 28,869 shares; 2026Q2: 35,040 shares 35,040$6.16M0.53%+6,171Timeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 455,286 shares 455,286$6.15M0.53%newTimeline
OCSOCULIS HOLDING AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 436,042 shares 436,042$6.05M0.53%newTimeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 101,250 shares; 2025Q3: 115,596 shares; 2025Q4: not reported; 2026Q1: 60,004 shares; 2026Q2: 22,077 shares 22,077$5.99M0.52%-37,927Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 31,878 shares; 2026Q1: 26,664 shares; 2026Q2: 43,264 shares 43,264$5.77M0.5%+16,600Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 36,701 shares 36,701$5.51M0.48%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 710,255 shares; 2024Q4: 158,746 shares; 2025Q1: 53,349 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 52,155 shares 52,155$5.46M0.47%newTimeline
BLTEBELITE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 19,823 shares; 2026Q1: 59,432 shares; 2026Q2: 34,803 shares 34,803$5.36M0.47%-24,629Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 40,400 shares; 2025Q2: 56,594 shares; 2025Q3: 115,073 shares; 2025Q4: 68,248 shares; 2026Q1: 126,383 shares; 2026Q2: 91,550 shares 91,550$4.91M0.43%-34,833Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 152,129 shares 152,129$4.69M0.41%newTimeline
CRLCHARLES RIV LABS INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 18,747 shares 18,747$4.25M0.37%newTimeline
ELANELANCO ANIMAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 207,311 shares; 2026Q1: not reported; 2026Q2: 172,489 shares 172,489$4.24M0.37%newTimeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 86,832 shares; 2024Q4: 63,699 shares; 2025Q1: 68,999 shares; 2025Q2: 7,237 shares; 2025Q3: 6,403 shares; 2025Q4: 4,202 shares; 2026Q1: 4,535 shares; 2026Q2: 4,482 shares 4,482$4.16M0.36%-53Timeline
BIOBIO RAD LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 13,995 shares 13,995$4.11M0.36%newTimeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 46,217 shares 46,217$4.1M0.36%newTimeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 221,505 shares; 2025Q4: 79,310 shares; 2026Q1: 71,894 shares; 2026Q2: 70,971 shares 70,971$3.92M0.34%-923Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 31,536 shares 31,536$3.69M0.32%newTimeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 182,810 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 227,003 shares; 2026Q1: 227,406 shares; 2026Q2: 192,442 shares 192,442$3.5M0.3%-34,964Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 451,267 shares; 2024Q4: 451,267 shares; 2025Q1: 451,267 shares; 2025Q2: 1,779,259 shares; 2025Q3: 1,662,836 shares; 2025Q4: 779,618 shares; 2026Q1: 1,367,099 shares; 2026Q2: 247,589 shares 247,589$3.5M0.3%-1,119,510Timeline
HCAHCA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 124,840 shares; 2024Q4: 69,441 shares; 2025Q1: 77,464 shares; 2025Q2: 72,290 shares; 2025Q3: 65,773 shares; 2025Q4: 13,865 shares; 2026Q1: 13,351 shares; 2026Q2: 8,295 shares 8,295$3.23M0.28%-5,056Timeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 152,779 shares; 2024Q4: 54,357 shares; 2025Q1: 140,681 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 123,831 shares; 2026Q2: 122,221 shares 122,221$2.94M0.26%-1,610Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,966 shares 100,966$2.6M0.23%newTimeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 423,910 shares; 2024Q4: 206,871 shares; 2025Q1: 926,424 shares; 2025Q2: not reported; 2025Q3: 256,488 shares; 2025Q4: 242,967 shares; 2026Q1: 245,021 shares; 2026Q2: 118,422 shares 118,422$2.59M0.22%-126,599Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 834,135 shares; 2025Q2: 732,256 shares; 2025Q3: 436,156 shares; 2025Q4: 134,549 shares; 2026Q1: 145,275 shares; 2026Q2: 143,700 shares 143,700$2.58M0.22%-1,575Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 27,338 shares; 2026Q1: 80,226 shares; 2026Q2: 40,579 shares 40,579$2.55M0.22%-39,647Timeline
OMOUTSET MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,685,727 shares; 2025Q2: 1,664,727 shares; 2025Q3: 1,729,921 shares; 2025Q4: 530,796 shares; 2026Q1: 594,630 shares; 2026Q2: 582,122 shares 582,122$2.51M0.22%-12,508Timeline
OMDAOMADA HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 114,442 shares 114,442$2.51M0.22%newTimeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,876,911 shares; 2024Q4: 4,390,427 shares; 2025Q1: 3,489,559 shares; 2025Q2: 1,072,224 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 134,088 shares 134,088$2.46M0.21%newTimeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 53,287 shares; 2025Q3: 80,493 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 7,385 shares 7,385$2.09M0.18%newTimeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 207,357 shares 207,357$2.07M0.18%newTimeline
OMCLOMNICELL COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 49,040 shares 49,040$2.04M0.18%newTimeline
CVRXCVRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 369,572 shares 369,572$1.9M0.16%newTimeline
HIMSHIMS & HERS HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 22,915 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 49,454 shares 49,454$1.71M0.15%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 47,637 shares; 2026Q1: 142,677 shares; 2026Q2: 62,418 shares 62,418$1.68M0.15%-80,259Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 42,724 shares; 2026Q1: 46,129 shares; 2026Q2: 45,631 shares 45,631$1.57M0.14%-498Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 121,628 shares; 2024Q4: 283,158 shares; 2025Q1: 599,967 shares; 2025Q2: 174,331 shares; 2025Q3: 46,353 shares; 2025Q4: 39,499 shares; 2026Q1: 42,635 shares; 2026Q2: 26,396 shares 26,396$1.22M0.11%-16,239Timeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 434,134 shares; 2025Q3: 452,733 shares; 2025Q4: 206,265 shares; 2026Q1: 128,726 shares; 2026Q2: 127,289 shares 127,289$662K0.06%-1,437Timeline
CRBUCARIBOU BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 4,306,671 shares; 2024Q4: 3,876,462 shares; 2025Q1: 2,506,435 shares; 2025Q2: 1,358,831 shares; 2025Q3: 1,358,831 shares; 2025Q4: 957,787 shares; 2026Q1: 957,787 shares; 2026Q2: 354,687 shares 354,687$624K0.05%-603,100Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
CORCENCORA INC Stockcall28,100$7.95Mnew
CNCCENTENE CORP DEL Stockput88,200$5.66Mnew

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
XBISPDR SERIES TRUST455,300$58.2Mput
XLVSELECT SECTOR SPDR TR238,900$35Mcall
ASNDASCENDIS PHARMA A/S152,034$34.8Mshares
UTHRUNITED THERAPEUTICS CORP DEL45,900$27.2Mput
GKOSGLAUKOS CORP215,685$23.2Mshares
CNTACENTESSA PHARMACEUTICALS PLC528,224$21Mshares
UTHRUNITED THERAPEUTICS CORP DEL31,700$18.8Mcall
ASCENDIS PHARMA A/SASCENDIS PHARMA A/S11,505,000$16.9Mprincipal
NEONEOGENOMICS INC1,784,552$13.2Mshares
DXCMDEXCOM INC149,734$9.4Mshares
TERNTERNS PHARMACEUTICALS INC172,962$9.12Mshares
SLNOSOLENO THERAPEUTICS INC248,180$8.31Mshares
BLLNBILLIONTOONE INC88,069$6.95Mshares
CAHCARDINAL HEALTH INC31,941$6.75Mshares
ALHCALIGNMENT HEALTHCARE INC359,826$6.34Mshares
PSNLPERSONALIS INC870,097$5.54Mshares
ASNDASCENDIS PHARMA A/S22,400$5.12Mcall
MDLNMEDLINE INC86,777$3.86Mshares
HCAHCA HEALTHCARE INC4,600$2.18Mput
GMEDGLOBUS MED INC16,923$1.46Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001442756-26-000006 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001442756-26-000006 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001442756-26-000002 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001442756-26-000001 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001442756-25-000007 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001085146-25-005245 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001085146-25-003307 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001104659-25-014169 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001104659-24-119211 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001104659-24-089590 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001104659-24-061155 Quarter ended 2024-03-312024-05-14acceptance time not in the bulk data set
13F-HR 0001104659-24-023577 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001104659-23-118110 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001104659-23-091299 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001104659-23-060725 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001104659-23-021550 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001104659-22-118494 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001104659-22-091330 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001104659-22-061272 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001104659-22-022959 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001104659-21-139147 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001104659-21-106268 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001104659-21-068018 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR/A 0001104659-21-025741 Quarter ended 2020-12-312021-02-19acceptance time not in the bulk data set
13F-HR 0001104659-21-023941 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001104659-20-125785 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001104659-20-095509 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001104659-20-062607 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001104659-20-022005 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001104659-19-064191 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001144204-19-040048 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001144204-19-026562 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001144204-19-008242 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001144204-18-059341 Quarter ended 2018-09-302018-11-13acceptance time not in the bulk data set
13F-HR 0001144204-18-044641 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001144204-18-028874 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001144204-18-008894 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001144204-17-059000 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001144204-17-043176 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001144204-17-027457 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001144204-17-008877 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0001144204-16-134272 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001144204-16-119462 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0001144204-16-102548 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0001144204-16-082684 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR 0001144204-15-066040 Quarter ended 2015-09-302015-11-16acceptance time not in the bulk data set
13F-HR 0001144204-15-049854 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0001144204-15-031628 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0001144204-15-010051 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set
13F-HR 0001144204-14-068833 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR 0001144204-14-050203 Quarter ended 2014-06-302014-08-14acceptance time not in the bulk data set
13F-HR 0001144204-14-031290 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR/A 0001144204-14-011010 Quarter ended 2013-12-312014-02-21acceptance time not in the bulk data set
13F-HR/A 0001144204-14-011009 Quarter ended 2013-09-302014-02-21acceptance time not in the bulk data set
13F-HR/A 0001144204-14-011005 Quarter ended 2013-03-312014-02-21acceptance time not in the bulk data set
13F-HR/A 0001144204-14-011007 Quarter ended 2013-06-302014-02-21acceptance time not in the bulk data set
13F-HR 0001144204-14-010003 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set
13F-HR 0001144204-13-061860 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR 0001144204-13-045879 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set